Today, we are ready to predict the stock prices of Nvax Inc. for the years 2024, 2025, 2028,2030 and 2035. It is basically a biotechnology company and works on the development of various innovative vaccines for patients in the world.
The company is engaged in the manufacturing and distribution of vaccines across the global network. However, when we look at its past, the stock price still remains the same, around $ 5.00 to $8.00, but in recent years, the company has shown huge growth.
According to its official Q2 2023 financial results, the company generated revenue of $424 million, an increase of $239 million, which is 129% more than Q2 2022 results.
At the same time, the company has reduced its combined expenses by $313 million, which has decreased by 85 million compared to the second quarter of 2022.
Nvax stock forecast for 2024 to 2035
Moreover, the company has also reduced its liabilities due in the first half of 2023 to $864 million from $1 billion. So, Novavax Inc. has shown strong financial results, still, its net income (loss) per share is 0.65 and diluted $0.58.
See also- PLTR Stock Forecast
Fundamentals of NVAX
2024
| Low | $10.24 |
| High | $15.32 |
2025
| Low | $18.10 |
| High | $24.50 |
2028
| Low | $28.15 |
| High | $35.22 |
2030
| Low | $38.41 |
| High | $44.32 |
2035
| Low | $55.10 |
| High | $63.22 |
NVAX future prospects:
Novavax, Inc. is a biotechnology company that specializes in the development of vaccines for various infectious diseases. According to our research and analysis, this is a good stock for the future. You can expect returns of up to 35 percent in the next two years.
If you invest $100 it could become $135 in the next two years. But, the top market analyst says that the price could reach $125.00 to $145.50.
Similar Stocks
Compound annual growth rate (CAGR)
The compound annual growth rate is a metric, usually a one-year CAGR of 10%, meaning it has grown 10% over the previous year.
| Year | Stock price |
|---|---|
| TTM | 9.71% |
| 2 years | 21.51% |
| 5 years | 28.21% |
| 10 years | 35.12% |
FAQs
The maximum stock price for NVAX shares in 2025 is $18.10 to $24.50.
The company has given average returns over the last few years and you cannot expect good returns in the near term.
The maximum stock price for Novavax shares by 2030 is $38.41 to $44.32.
At present there is a downward trend and now is a good opportunity to buy. Make sure you consult your financial advisor, as there are various risks involved.
Disclaimer: The stock price forecast for Novavax (NVX) is for general information only. You should not take this as financial advice, do your research and consult your financial advisor.
